当前位置: 首页 > 详情页

Distinct virtual histology of grey matter atrophy in four neuroinflammatory diseases

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Department of Radiology, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100070, P.R. China. [2]Tiantan Image Research Center, China National Clinical Research Center for Neurological Diseases, Beijing, 100070, P.R. China. [3]Department of Medical Imaging Product, Neusoft, Group Ltd., Shenyang, 110179, P.R. China. [4]Department of Radiology, Xuanwu Hospital, Capital Medical University, Beijing, 100053, P. R. China. [5]Department of Radiology, The First Affiliated Hospital, Nanchang University, Nanchang, Jiangxi Province, 330006, P. R. China. [6]Department of Radiology, Huashan Hospital, Fudan University, Shanghai, 200040, China. [7]Department of Radiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, P. R. China. [8]Department of Neurology, China-Japan Union Hospital of Jilin University, Changchun, Jilin Province, 130031, P. R. China. [9]China National Clinical Research Center for Neurological Diseases, Beijing, 100070, P. R. China. [10]Department of Neurology and Tianjin Neurological Institute, Tianjin Medical University General Hospital, Tianjin, 300052, P. R. China. [11]Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100070, P. R. China.
出处:
ISSN:

关键词: virtual histology grey matter atrophy multiple sclerosis NMOSD MOGAD

摘要:
Gray matter (GM) atrophies were observed in multiple sclerosis, neuromyelitis optica spectrum disorders (both anti-aquaporin-4 antibody-positive [AQP4+], and -negative [AQP4-] subtypes NMOSD), and myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD). Revealing the pathogenesis of brain atrophy in these disorders would help their differential diagnosis and guide therapeutic strategies. To determine the neurobiological underpinnings of GM atrophies in multiple sclerosis, AQP4+ NMOSD, AQP4- NMOSD, and MOGAD, we conducted a virtual histology analysis that links T1-weighted image derived GM atrophy and gene expression using a multicenter cohort of 324 patients with multiple sclerosis, 197 patients with AQP4+ NMOSD, 75 patients with AQP4- NMOSD, 47 patients with MOGAD, and 2,169 healthy controls (HCs). First, interregional GM atrophy profiles across the cortical and subcortical regions were determined by Cohen's d between patients with multiple sclerosis, AQP4+ NMOSD, AQP4- NMOSD, MOGAD and HCs. Then, the GM atrophy profiles were spatially correlated with the gene expressions extracted from the Allen Human Brain Atlas, respectively. Finally, we explored the virtual histology of clinical feature relevant GM atrophy by subgroup analysis that stratified by physical disability, disease duration, number of relapses, lesion burden, and cognitive function. Multiple sclerosis showed severe widespread GM atrophy pattern, mainly involving subcortical nuclei and brainstem. AQP4+ NMOSD showed obvious widespread GM atrophy pattern, predominately located in occipital cortex as well as cerebellum. AQP4- NMOSD showed mild widespread GM atrophy pattern, mainly located in frontal and parietal cortices. MOGAD showed GM atrophy mainly involving the frontal and temporal cortices. High expression of genes specific to microglia, astrocytes, oligodendrocytes, and endothelial cells in multiple sclerosis, S1 pyramidal cells in AQP4+ NMOSD, as well as S1 and CA1 pyramidal cells in MOGAD had spatial correlations with GM atrophy profiles were observed, while no atrophy profile related gene expression was found in AQP4- NMOSD. Virtual histology of clinical feature relevant GM atrophy mainly pointed to the shared neuronal and endothelial cells among the four neuroinflammatory diseases. The unique underlying virtual histology patterns were microglia, astrocytes, and oligodendrocytes for multiple sclerosis; astrocytes for AQP4+ NMOSD; and oligodendrocytes for MOGAD. Neuronal and endothelial cells were shared potential targets across these neuroinflammatory diseases. These findings might help their differential diagnosis and optimal therapeutic strategies.© The Author(s) 2024. Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com.

基金:
语种:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2023]版:
大类 | 1 区 医学
小类 | 1 区 临床神经病学 1 区 神经科学
最新[2023]版:
大类 | 1 区 医学
小类 | 1 区 临床神经病学 1 区 神经科学
JCR分区:
出版当年[2022]版:
Q1 CLINICAL NEUROLOGY Q1 NEUROSCIENCES
最新[2023]版:
Q1 CLINICAL NEUROLOGY Q1 NEUROSCIENCES

影响因子: 最新[2023版] 最新五年平均 出版当年[2022版] 出版当年五年平均 出版前一年[2021版] 出版后一年[2023版]

第一作者:
第一作者机构: [1]Department of Radiology, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100070, P.R. China. [2]Tiantan Image Research Center, China National Clinical Research Center for Neurological Diseases, Beijing, 100070, P.R. China.
共同第一作者:
通讯作者:
通讯机构: [1]Department of Radiology, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100070, P.R. China. [2]Tiantan Image Research Center, China National Clinical Research Center for Neurological Diseases, Beijing, 100070, P.R. China. [*1]Department of Radiology, Beijing Tiantan Hospital, Capital Medical University. No.119, the West Southern 4th Ring Road, Fengtai District, Beijing, 100070, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16470 今日访问量:0 总访问量:871 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院